India in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD07761
Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 123
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

India in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the India IIn vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in India

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in India.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in India.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 In Vitro Diagnostics
    • 3.2 Clinical Chemistry Test Reagents
      • 3.2.1 Laboratory Reagents
      • 3.2.2 Clinical Chemistry Calibrators and Controls
      • 3.2.3 Clinical Chemistry Rapid Tests
    • 3.3 Immunochemistry Test Reagents
      • 3.3.1 Disease Specific Markers
        • 3.3.1.1 Tumor Markers
        • 3.3.1.2 Cardiac Markers
      • 3.3.2 Disease Specific Test Reagents
        • 3.3.2.1 Auto-Immune Disease
        • 3.3.2.2 Rheumatoid Disease
        • 3.3.2.3 Anemia/ Vitamins
        • 3.3.2.4 Allergy
      • 3.3.3 Drug Related Testing Reagents
        • 3.3.3.1 Therapeutic Drugs
        • 3.3.3.2 Drug of Abuse and Toxicology
      • 3.3.4 Hormone Related Testing Reagents
        • 3.3.4.1 Specific Proteins
        • 3.3.4.2 Fertility and Pregnancy
        • 3.3.4.3 Individual/Specified hormones
        • 3.3.4.4 Specific Organ Function
      • 3.3.5 Immunochemistry Calibrators and Controls
      • 3.3.6 Immunochemistry Rapid Tests
    • 3.4 Blood Test Reagents
      • 3.4.1 Hematology Test Reagents
        • 3.4.1.1 Hematology
        • 3.4.1.2 Immunohaematology
        • 3.4.1.3 Hematology Calibrators and Controls
        • 3.4.1.4 Immunohaematology Controls
      • 3.4.2 Hemostasis Test Reagents
        • 3.4.2.1 Hemostasis
        • 3.4.2.2 Hemostasis Calibrators and Controls
        • 3.4.2.3 Hemostasis Rapid Tests
      • 3.4.3 Tissue Typing Reagents
      • 3.4.4 Monoclonal Antibodies
      • 3.4.5 Cytokines and Immunomodulators
      • 3.4.6 Histology and Cytology Reagents
    • 3.5 Microbiology Test Reagents
      • 3.5.1 Bacteriology Test Reagents
        • 3.5.1.1 Bacteriology Culture
        • 3.5.1.2 Blood Culture
        • 3.5.1.3 Bacteriology Identification and Susceptibility
      • 3.5.2 Microbiology Calibrators and Controls
      • 3.5.3 Microbiology Rapid Tests
    • 3.6 Infectious Immunology Test Reagents
      • 3.6.1 Bacteriology
      • 3.6.2 Virology
        • 3.6.2.1 Hepatitis Viruses
        • 3.6.2.2 Retroviruses
      • 3.6.3 Parasitology
      • 3.6.4 Infectious Immunology Calibrators and Controls
      • 3.6.5 Infectious Immunology Rapid Tests
    • 3.7 Genetic Test Reagents
    • 3.8 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
      • 4.2.1 Healthcare Personnel Data
      • 4.2.2 Healthcare Facilities Data
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval
    • 5.2 Central Drugs Authority of India (CDAI)
    • 5.3 Medical Device Regulatory Authority of India (MDRAI)
    • 5.4 Classification of medical devices
      • 5.4.1 Registration Period
  • 6 Pricing and Reimbursement
    • 6.1 Pricing and Reimbursement
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 In Vitro Diagnostics In India
    • 8.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
    • 8.3 In Vitro Diagnostics, India, Company Share (2006-2007)
  • 9 Blood Test Reagents In India
    • 9.1 Blood Test Reagents Overall Revenue (2000-2015)
      • 9.1.1 Haematology Test Reagents Revenue (2000-2015)
      • 9.1.2 Hemostasis Test Reagents (Hemostasis) Revenue (2000-2015)
    • 9.2 Blood Test Reagents Distribution Share (2007-2008)
    • 9.3 Blood Test Reagents, India, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In India
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2007-2008)
    • 10.3 Clinical Chemistry Test Reagents, India, Company Share (2006-2007)
  • 11 Immunochemistry Test Reagents In India
    • 11.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
      • 11.1.1 Disease Specific Markers Revenue (2000-2015)
      • 11.1.2 Disease Specific Test Reagents Revenue (2000-2015)
      • 11.1.3 Hormone Related Testing Reagents Revenue (2000-2015)
    • 11.2 Immunochemistry Test Reagents Distribution Share (2007-2008)
    • 11.3 Immunochemistry Test Reagents, India, Company Share (2006-2007)
  • 12 Infectious Immunology Test Reagents In India
    • 12.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
    • 12.2 Infectious Immunology Test Reagents Distribution Share (2007-2008)
    • 12.3 Infectious Immunology Test Reagents, India, Company Share (2006-2007)
  • 13 Instruments In India
    • 13.1 Instruments Overall Revenue (2000-2015)
    • 13.2 Instruments Distribution Share (2007-2008)
    • 13.3 Instruments, India, Company Share (2006-2007)
  • 14 Microbiology Test Reagents In India
    • 14.1 Microbiology Test Reagents Overall Revenue (2000-2015)
      • 14.1.1 Bacteriology Test Reagents Revenue (2000-2015)
    • 14.2 Microbiology Test Reagents Distribution Share (2007-2008)
    • 14.3 Microbiology Test Reagents, India, Company Share (2006-2007)
  • 15 Overview of Key Companies in India In Vitro Diagnostics Market
    • 15.1 Transasia Bio-Medicals Ltd
      • 15.1.1 Company Overview
    • 15.2 Abbott Laboratories
      • 15.2.1 Company Overview
      • 15.2.2 Value Chain Analysis
        • 15.2.2.1 Manufacturing
        • 15.2.2.2 Product Development
        • 15.2.2.3 Sales and Marketing
    • 15.3 Ortho-Clinical Diagnostics Inc
      • 15.3.1 Company Overview
      • 15.3.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
        • 15.3.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type
        • 15.3.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
        • 15.3.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
        • 15.3.2.4 Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • 15.4 F. Hoffmann-La Roche Ltd
      • 15.4.1 Company Overview
      • 15.4.2 Value Chain Analysis
        • 15.4.2.1 Manufacturing
        • 15.4.2.2 Product Development
    • 15.5 Beckman Coulter, Inc
      • 15.5.1 Company Overview
      • 15.5.2 Value Chain Analysis
        • 15.5.2.1 Manufacturing
        • 15.5.2.2 Product Development
        • 15.5.2.3 Sales and Marketing
      • 15.5.3 Beckman Coulter, Inc. Pipeline Products
        • 15.5.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type
        • 15.5.3.2 Beckman Coulter, Inc. Pipeline Products By Development Stage
        • 15.5.3.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area
        • 15.5.3.4 Beckman Coulter, Inc. Pipeline Products By News Summary
    • 15.6 Siemens Healthcare
      • 15.6.1 Company Overview
      • 15.6.2 Value Chain Analysis
        • 15.6.2.1 Manufacturing
        • 15.6.2.2 Product Development
        • 15.6.2.3 Sales and Marketing
    • 15.7 Dade Behring Holdings, Inc
      • 15.7.1 Company Overview
    • 15.8 Gen-Probe Incorporated
      • 15.8.1 Company Overview
      • 15.8.2 Value Chain Analysis
        • 15.8.2.1 Manufacturing
        • 15.8.2.2 Product Development
        • 15.8.2.3 Sales and Marketing
      • 15.8.3 Gen-Probe Incorporated Pipeline Products
        • 15.8.3.1 Gen-Probe Incorporated Pipeline Products By Equipment Type
        • 15.8.3.2 Gen-Probe Incorporated Pipeline Products By Development Stage
        • 15.8.3.3 Gen-Probe Incorporated Pipeline Products By Therapy Area
        • 15.8.3.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials
        • 15.8.3.5 Gen-Probe Incorporated Pipeline Products By News Summary
    • 15.9 Becton, Dickinson and
      • 15.9.1 Company Overview
      • 15.9.2 Value Chain Analysis
        • 15.9.2.1 Manufacturing
        • 15.9.2.2 Product Development
        • 15.9.2.3 Sales and Marketing
    • 15.10 bioMerieux S.A
      • 15.10.1 Company Overview
      • 15.10.2 Value Chain Analysis
        • 15.10.2.1 Manufacturing
        • 15.10.2.2 Product Development
        • 15.10.2.3 Sales and Marketing
    • 15.11 OLYMPUS CORPORATION
      • 15.11.1 Company Overview
      • 15.11.2 Value Chain Analysis
        • 15.11.2.1 Manufacturing
        • 15.11.2.2 Product Development
        • 15.11.2.3 Sales and Marketing
      • 15.11.3 Olympus Medical Systems Corp. Pipeline Products
        • 15.11.3.1 Olympus Medical Systems Corp. Pipeline Products by Equipment Type
        • 15.11.3.2 Olympus Medical Systems Corp. Pipeline Products by Development Stage
        • 15.11.3.3 Olympus Medical Systems Corp. Pipeline Products by Therapy Area
        • 15.11.3.4 Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
        • 15.11.3.5 Olympus Medical Systems Corp. Pipeline Products by News Summary
    • 15.12 Agappe Diagnostics Ltd
      • 15.12.1 Company Overview
    • 15.13 Transasia Bio-Medicals Ltd
      • 15.13.1 Company Overview
    • 15.14 Narang Medical Limited
      • 15.14.1 Company Overview
    • 15.15 Bhat Bio-tech India (P)Ltd
      • 15.15.1 Company Overview
    • 15.16 Professional Biotech Pvt. Ltd
      • 15.16.1 Company Overview
    • 15.17 Span Diagnostics Ltd
      • 15.17.1 Company Overview
    • 15.18 Accurex Biomedical Pvt. Ltd
      • 15.18.1 Company Overview
    • 15.19 Invitro Biotech Ltd
      • 15.19.1 Company Overview
    • 15.20 Medicare Products Inc
      • 15.20.1 Company Overview
    • 15.21 RFCL Limited
      • 15.21.1 Company Overview
  • 16 Recent Developments
    • 16.1 Strategy and Business Planning
      • 16.1.1 Feb 04, 2009: Biofield Expands Arsenal of Non-Invasive Diagnostic Devices
    • 16.2 Government and Public Interest
      • 16.2.1 Mar 26, 2009: Obama US Stem Cell Policy May Benefit India
      • 16.2.2 Jan 27, 2009: Diagnostics and Laboratory Tests Outsourcing To India Hindered By Regulations
    • 16.3 Product News
      • 16.3.1 Apr 01, 2009: Landmark Study Shows Significant Reduction in Death Rate from Cervical Cancer with The Digene HPV Test Compared To Other Methods Including Pap
      • 16.3.2 Feb 24, 2009: Zila Launches ViziLite Plus In India
      • 16.3.3 Jan 06, 2009: Xenomics Presents HPV Test Based On Proprietary Technology At 52nd All India Congress Of Obstetrics & Gynecology
      • 16.3.4 Nov 10, 2008: Diagenic Announces Launch Of First Breast Cancer Gene-Expression Blood Test
      • 16.3.5 Nov 08, 2008: World Premiere Of A Revolutionary Breast Cancer Test
  • 17 Appendix
    • 17.1 Global Markets Direct Research Methodology
    • 17.2 Coverage
    • 17.3 Secondary Research
    • 17.4 Primary Research
    • 17.5 Models
    • 17.6 Forecasts
    • 17.7 Expert Panel Validation
    • 17.8 Currency Conversion
    • 17.9 Contact Us
    • 17.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Doctors by Specialty in India, 2000-2006
    • Table 2: Wards by Specialty in India, 2000-2006
    • Table 3: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 4: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
    • Table 5: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015
    • Table 6: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 7: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 8: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 9: Blood Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 10: Blood Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 11: Haematology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 12: Haematology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 13: Hemostasis Test Reagents (Hemostasis), India, Revenue ($ mn), Historic, 2000-2008
    • Table 14: Hemostasis Test Reagents (Hemostasis), India, Revenue ($ mn), Forecast, 2008-2015
    • Table 15: Blood Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 16: Blood Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 17: Clinical Chemistry Test Reagents(Laboratory Reagents), India, Revenue ($ mn), Historic, 2000-2008
    • Table 18: Clinical Chemistry Test Reagents(Laboratory Reagents), India, Revenue ($ mn), Forecast, 2008-2015
    • Table 19: Clinical Chemistry Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 20: Clinical Chemistry Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 22: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 23: Disease Specific Markers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 24: Disease Specific Markers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 25: Disease Specific Test Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 26: Disease Specific Test Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 27: Hormone Related Testing Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 28: Hormone Related Testing Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 29: Immunochemistry Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 30: Immunochemistry Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: Infectious Immunology Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 32: Infectious Immunology Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 33: Infectious Immunology Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 34: Infectious Immunology Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Instruments, India, Revenue ($ mn), Historic, 2000-2008
    • Table 36: Instruments, India, Revenue ($ mn), Forecast, 2008-2015
    • Table 37: Instruments, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 38: Instruments, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 39: Microbiology Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 40: Microbiology Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 41: Bacteriology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 42: Bacteriology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 43: Microbiology Test Reagents, India, Distribution Share by Revenue ($mn), 2007-2008
    • Table 44: Microbiology Test Reagents, India, Company Share by Revenue ($ mn), 2006-2007
    • Table 45: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
    • Table 46: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
    • Table 47: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
    • Table 48: Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • Table 49: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 50: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 51: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 52: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 53: Gen-Probe Incorporated Pipeline Products by Equipment Type
    • Table 54: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Table 55: Gen-Probe Incorporated Pipeline Products By Therapy Area
    • Table 56: Gen-Probe Incorporated Pipeline Products By Clinical Trials
    • Table 57: Gen-Probe Incorporated Pipeline Products By News Summary
    • Table 58: Olympus Medical Systems Corp. Pipeline Products by Equipment Type
    • Table 59: Olympus Medical Systems Corp. Pipeline Products by Development Stage
    • Table 60: Olympus Medical Systems Corp. Pipeline Products by Therapy Area
    • Table 61: Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
    • Table 62: Olympus Medical Systems Corp. Pipeline Products by News Summary
    • Table 63: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in India, 2000-2005
    • Figure 2: Private Expenditure on Health by Source, 2005
    • Figure 3: Proposed Medical Equipment Classification in India, 2005
    • Figure 4: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 5: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015
    • Figure 6: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015
    • Figure 7: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 8: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 9: In Vitro Diagnostics, India, Company Share (%), 2007
    • Figure 10: Blood Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 11: Blood Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 12: Haematology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 13: Haematology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 14: Hemostasis Test Reagents (Hemostasis), India, Revenue ($ mn), Historic, 2000-2008
    • Figure 15: Hemostasis Test Reagents (Hemostasis), India, Revenue ($ mn), Forecast, 2008-2015
    • Figure 16: Blood Test Reagents, India, Company Share (%), 2007
    • Figure 17: Clinical Chemistry Test Reagents(Laboratory Reagents), India, Revenue ($ mn), Historic, 2000-2008
    • Figure 18: Clinical Chemistry Test Reagents(Laboratory Reagents), India, Revenue ($ mn), Forecast, 2008-2015
    • Figure 19: Clinical Chemistry Test Reagents, India, Company Share (%), 2007
    • Figure 20: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 21: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 22: Disease Specific Markers, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 23: Disease Specific Markers, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 24: Disease Specific Test Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Disease Specific Test Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Hormone Related Testing Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 27: Hormone Related Testing Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 28: Immunochemistry Test Reagents, India, Company Share (%), 2007
    • Figure 29: Infectious Immunology Test Reagents, India, Company Share (%), 2007
    • Figure 30: Instruments, India, Revenue ($ mn), Historic, 2000-2008
    • Figure 31: Instruments, India, Revenue ($ mn), Forecast, 2008-2015
    • Figure 32: Instruments, India, Company Share (%), 2007
    • Figure 33: Microbiology Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 34: Microbiology Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 35: Bacteriology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 36: Bacteriology Test Reagents, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 37: Microbiology Test Reagents, India, Company Share (%), 2007
    • Figure 38: Abbott Laboratories Value Chain Analysis
    • Figure 39: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 40: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 41: Siemens Medical Solutions Value Chain Analysis
    • Figure 42: Gen-Probe Incorporated Value Chain Analysis
    • Figure 43: Becton, Dickinson and Company Value Chain Analysis
    • Figure 44: Biomerieux Sa Value Chain Analysis
    • Figure 45: Olympus Medical Systems Corp. Value Chain Analysis
    • Figure 46: Global Markets Direct Methodology